Mixed bag for AstraZeneca sNDAs

AstraZeneca (LSE:AZN; NYSE:AZN) said FDA issued a complete response letter for an sNDA for Seroquel XR quetiapine to treat generalized anxiety disorder (GAD) in adults. The company said FDA proposed l...